These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19095688)

  • 1. Implantable cardioverter defibrillator lead diaphragmatic perforation.
    Manolis AG; Chatzis D; Kouvelas KG
    Europace; 2009 Feb; 11(2):271. PubMed ID: 19095688
    [No Abstract]   [Full Text] [Related]  

  • 2. External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.
    Dell'Era G; Magnani A; Occhetta E
    Europace; 2015 Nov; 17(11):1726. PubMed ID: 26462698
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumomediastinum after implantable cardiac defibrillator implantation.
    Girerd N; Lienhart AS; Chevalier P
    Eur Heart J; 2011 Feb; 32(4):429. PubMed ID: 20926366
    [No Abstract]   [Full Text] [Related]  

  • 4. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium.
    Sakai Y; Sato Y; Matsuo S; Imai S; Kunimasa T; Matsumoto N; Saito S
    Int J Cardiol; 2007 May; 117(3):e104-6. PubMed ID: 17350119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator.
    Alasti M; Machado C; Kotschet E; Alison J
    Heart Lung Circ; 2019 Apr; 28(4):e88-e90. PubMed ID: 30482685
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporary external implantable cardioverter defibrillator in the pacemaker-dependent ventricular tachycardia patient.
    Cooper JM; Lavi N; Polin GM; Dixit S; Verdino RJ
    Europace; 2011 May; 13(5):761-3. PubMed ID: 21106578
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator.
    Haghjoo M; Hajahmadi M; Fazelifar AF; Sadr-Ameli MA
    Europace; 2011 Apr; 13(4):509-13. PubMed ID: 21296776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

  • 9. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 11. Twiddler syndrome as a rare cause of implantable cardioverter defibrillator malfunction.
    Gungor H; Duygu H; Yildiz BS; Gul I; Zoghi M; Akin M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):352-3. PubMed ID: 19430349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator. Evaluation of clinical neurologic outcome and electroencephalographic changes during implantation.
    Adams DC; Heyer EJ; Emerson RG; Spotnitz HM; Delphin E; Turner C; Berman MF
    J Thorac Cardiovasc Surg; 1995 Mar; 109(3):565-73. PubMed ID: 7877320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extreme electrical storm in a patient with an implantable cardioverter defibrillator.
    Sela R; Gellerman M; Kalfon E; Atar S
    Isr Med Assoc J; 2014 Aug; 16(8):513-5. PubMed ID: 25269346
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate ICD discharges due to diaphragmatic electromyopotential oversensing as the first sign of right ventricular lead perforation.
    Wiegand UK; Wilke I; Bonnemeier H; Eberhardt F; Bode F
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1176-8. PubMed ID: 17038150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point: implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias increase mortality.
    Sweeney MO
    Heart Rhythm; 2012 Jun; 9(6):985-7. PubMed ID: 22120131
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of subacute and delayed right ventricular perforation with a pacing or an implantable cardioverter-defibrillator lead.
    Laborderie J; Barandon L; Ploux S; Deplagne A; Mokrani B; Reuter S; Le Gal F; Jais P; Haissaguerre M; Clementy J; Bordachar P
    Am J Cardiol; 2008 Nov; 102(10):1352-5. PubMed ID: 18993154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachycardia-induced cardiomyopathy unmasked with implantable cardioverter defibrillator implantation.
    Danon A; Singh SM
    Can J Cardiol; 2013 Oct; 29(10):1330.e9-1330.e10. PubMed ID: 23993688
    [No Abstract]   [Full Text] [Related]  

  • 20. Wide QRS complex tachycardia in a patient with a biventricular implantable cardioverter defibrillator: what is the mechanism?
    Arias MA; Puchol A; Pachón M; Briz C
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):334-7. PubMed ID: 24237963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.